Now showing items 1-1 of 1
Estimating the inpatient and outpatient costs of atrial fibrillation and associated adverse events
<bold>ABSTRACT</bold> <bold>Background</bold> In the last several years three new anticoagulant options have come on to the market, altering the risk/benefit profile of stroke prevention therapy. The development of useful decision analytic models in atrial fibrillation (AF) is contingent on accurate estimates of costs. Estimated ...